Shenghua Wen

Years Active: 2020-2020
Publications (10 Years): 1

AstraZeneca R&D Boston

This page only lists publications with an associated author ORCID identifier.

Affiliation History

AstraZeneca R&D Boston

United States

Sr Scientist :: Pharmacology

Publications

Srividya B Balachander, Steven W Criscione, Kate F Byth, Justin Cidado, Ammar Adam, Paula Lewis, Terry Macintyre, Shenghua Wen, Deborah Lawson, Kathleen Burke, Tristan Lubinski, Jeffrey W Tyner, Stephen E Kurtz, Shannon K McWeeney, Jeffrey Varnes, R Bruce Diebold, Thomas Gero, Stephanos Ioannidis, Edward J Hennessy, William McCoull, Jamal C Saeh, Areya Tabatabai, Omid Tavana, Nancy Su, Alwin Schuller, Mathew J Garnett, Patricia Jaaks, Elizabeth A Coker, Gareth Peter Gregory, Andrea Newbold, Ricky W Johnstone, Eric Gangl, Martin Wild, Michael Zinda, J Paul Secrist, Barry R Davies, Stephen E Fawell, Francis D Gibbons
AZD4320, A Dual Inhibitor of Bcl-2 and Bcl-xL, Induces Tumor Regression in Hematologic Cancer Models without Dose-limiting Thrombocytopenia. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (24) (2020)

Shenghua Wen.css-eqlu8i{font-size:small;padding-left:4px;}